ANXA13 and focal segmental glomerulosclerosis: ANXA13 binds to negatively charged membrane phospholipids in a calcium-dependent manner and was shown to play a role in FSGS kidney evolution to CKD; on the other hand, ANXA13 has the potential to be a biomarker of disease evolution.